These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17143440)
61. Editorial: mesalazine in ulcerative colitis--is it time to revise treatment guidelines in the UK? Travis SP Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():1. PubMed ID: 16939422 [No Abstract] [Full Text] [Related]
62. What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis. Rubin DT Gastroenterology; 2013 Jul; 145(1):45-47. PubMed ID: 23726879 [No Abstract] [Full Text] [Related]
64. Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad. Faubion WA; Sandborn WJ Gastroenterology; 2000 Mar; 118(3):630-1. PubMed ID: 10702217 [No Abstract] [Full Text] [Related]
65. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool. American Gastroenterological Association Gastroenterology; 2019 Feb; 156(3):765. PubMed ID: 30684448 [No Abstract] [Full Text] [Related]
66. Ulcerative colitis treatment for children and teens. FDA Consum; 2007; 41(2):5. PubMed ID: 17582854 [No Abstract] [Full Text] [Related]
67. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316 [TBL] [Abstract][Full Text] [Related]
68. Acute pleuropericarditis in a patient with primary Sjögren's syndrome and quiescent ulcerative colitis in longstanding 5-aminosalicylic acid therapy. Qanneta R; García Pardo G; Florit Serra L J Crohns Colitis; 2013 Nov; 7(10):e506-7. PubMed ID: 23768863 [No Abstract] [Full Text] [Related]
69. Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis. Xinmei Z; Yan C Inflamm Bowel Dis; 2012 Apr; 18(4):E798-800. PubMed ID: 21987371 [No Abstract] [Full Text] [Related]
70. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy. Yamamoto T; Umegae S; Matsumoto K Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041 [TBL] [Abstract][Full Text] [Related]
71. A case of severe diverticulosis in a patient with ulcerative colitis. Dias E; Santos-Antunes J; Macedo G Rev Esp Enferm Dig; 2021 Jul; 113(7):550-551. PubMed ID: 33267601 [TBL] [Abstract][Full Text] [Related]
72. Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis. Agilli M; Dogan T; Ergin G Inflamm Bowel Dis; 2015 Aug; 21(8):E14-5. PubMed ID: 26083615 [No Abstract] [Full Text] [Related]
77. Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis. Pedersen N; Munkholm P Inflamm Bowel Dis; 2015 Aug; 21(8):E15-6. PubMed ID: 26111214 [No Abstract] [Full Text] [Related]
78. [Eosinophilic pneumonia caused by mesalazine. Report of one case]. Pérez C; Errázuriz I; Brockmann P; González S; Cofré C Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224 [TBL] [Abstract][Full Text] [Related]
79. A rare cause of diarrhea in patients with focal segmental glomerulosclerosis. Saglam O; Unverdi S; Duranay M Nefrologia; 2016; 36(3):320-1. PubMed ID: 26857203 [No Abstract] [Full Text] [Related]